This announcement is a separate document:
開拓藥業-B：自願公告 福瑞他恩治療脫髮完成首例患者入組，正式啓動III期臨床試驗
KINTOR PHARMA-B: VOLUNTARY ANNOUNCEMENT ENROLLMENT OF FIRST PATIENT AND INITIATION OF PHASE III CLINICAL TRIAL OF KX-826 FOR TREATMENT OF AGA
Jan 2, 2022 19:31
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.